Back to Search
Start Over
A Composite Endpoint for Treatment Benefit According to Patient Preference
- Source :
- Statistics in Biopharmaceutical Research. 14:408-422
- Publication Year :
- 2022
- Publisher :
- Informa UK Limited, 2022.
-
Abstract
- Complex disorders usually affect multiple symptom domains measured by several outcomes. The importance of these outcomes is often different among patients. Current approaches integrate multiple outcomes without considering patient preferences at the individual level. In this article, we propose a new composite Desirability of Outcome Ranking (DOOR) that integrates individual level ranking of outcome importance and define a winning probability measuring the overall treatment effect. Stratified randomization can be performed based on the participants’ baseline outcome rankings. A Wilcoxon-Mann-Whitney U-statistic is used to average the pairwise DOOR between one treated and one control patient, considering the difference in these patients’ ranking of outcome importance. We use both theoretical and empirical methods to examine the statistical properties of our method and to compare with conventional approaches. We conclude that the proposed composite DOOR properly reflects patient-level preferences and can be used in pivotal trials or comparative effectiveness trials for a patient-centered evaluation of overall treatment benefits.
- Subjects :
- Statistics and Probability
Pharmaceutical Science
Subjects
Details
- ISSN :
- 19466315
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Statistics in Biopharmaceutical Research
- Accession number :
- edsair.doi.dedup.....7daa65412865738fa15da88ec1db7104
- Full Text :
- https://doi.org/10.1080/19466315.2022.2085783